| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1003207022 |
| P356 | DOI | 10.1186/1756-6606-7-22 |
| P932 | PMC publication ID | 3977688 |
| P698 | PubMed publication ID | 24685317 |
| P5875 | ResearchGate publication ID | 261254975 |
| P50 | author | Shinya Yamanaka | Q80917 |
| Hideyuki Okano | Q11473927 | ||
| P2860 | cites work | Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies | Q48401512 |
| Fibroblast growth factor-2/brain-derived neurotrophic factor-associated maturation of new neurons generated from adult human subependymal cells | Q48470593 | ||
| Modeling brain disease in a dish: really? | Q48471179 | ||
| Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells | Q48876988 | ||
| Spatiotemporal recapitulation of central nervous system development by murine embryonic stem cell-derived neural stem/progenitor cells | Q48946379 | ||
| Inducing translation | Q50920504 | ||
| Transplantation of human neural stem cells for spinal cord injury in primates. | Q51527726 | ||
| Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats | Q57203221 | ||
| Immunogenicity of induced pluripotent stem cells | Q84949816 | ||
| Genome engineering using the CRISPR-Cas9 system | Q22122027 | ||
| Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase | Q22254584 | ||
| LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress | Q24294466 | ||
| PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 | Q24297155 | ||
| Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells | Q24300095 | ||
| Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism | Q24309753 | ||
| Hereditary early-onset Parkinson's disease caused by mutations in PINK1 | Q24337084 | ||
| Detection of ApoE E2, E3 and E4 alleles using MALDI-TOF mass spectrometry and the homogeneous mass-extend technology | Q24530740 | ||
| Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells | Q24616059 | ||
| Modelling schizophrenia using human induced pluripotent stem cells | Q24633007 | ||
| Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice | Q24635187 | ||
| Establishment in culture of pluripotential cells from mouse embryos | Q27860625 | ||
| Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families | Q27860677 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Embryonic stem cell lines derived from human blastocysts | Q27861010 | ||
| Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase | Q28116395 | ||
| A TALE nuclease architecture for efficient genome editing | Q28301656 | ||
| Viable offspring derived from fetal and adult mammalian cells | Q28304072 | ||
| Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells | Q28475963 | ||
| Generation of stratified squamous epithelial progenitor cells from mouse induced pluripotent stem cells | Q28478346 | ||
| The ground state of embryonic stem cell self-renewal | Q29547196 | ||
| Expression of a single transfected cDNA converts fibroblasts to myoblasts | Q29547764 | ||
| Induced pluripotent stem cells from a spinal muscular atrophy patient | Q29614340 | ||
| Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity | Q29615792 | ||
| Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells | Q29615870 | ||
| High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells | Q29616045 | ||
| Immunogenicity of induced pluripotent stem cells | Q29616185 | ||
| Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons | Q29616199 | ||
| Genetic engineering of human pluripotent cells using TALE nucleases | Q29619830 | ||
| A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells | Q29619964 | ||
| Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN). | Q37424645 | ||
| Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. | Q37444336 | ||
| Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. | Q37581657 | ||
| Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation | Q37660450 | ||
| Dominantly Inherited Alzheimer Network: facilitating research and clinical trials | Q37689963 | ||
| Genetics of neurodegenerative diseases: insights from high-throughput resequencing | Q37736129 | ||
| Induced pluripotent stem cells: a new revolution for clinical neurology? | Q37857439 | ||
| What genetics tells us about the causes and mechanisms of Parkinson's disease | Q37947563 | ||
| Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells | Q38066391 | ||
| Induced pluripotent stem cells in cardiovascular medicine | Q38603881 | ||
| APP processing in human pluripotent stem cell-derived neurons is resistant to NSAID-based γ-secretase modulation. | Q39039395 | ||
| Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons | Q39138608 | ||
| Neuropathology of Parkinson's disease | Q41095404 | ||
| Human iPSC-based modeling of late-onset disease via progerin-induced aging | Q41868474 | ||
| Olfactory cells via nasal biopsy reflect the developing brain in gene expression profiles: utility and limitation of the surrogate tissues in research for brain disorders | Q42735670 | ||
| Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients | Q42817044 | ||
| Modeling familial Alzheimer's disease with induced pluripotent stem cells | Q42817521 | ||
| Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease | Q42818202 | ||
| Drug screening for ALS using patient-specific induced pluripotent stem cells | Q42820289 | ||
| Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression | Q42823656 | ||
| Functional corneal endothelium derived from corneal stroma stem cells of neural crest origin by retinoic acid and Wnt/β-catenin signaling | Q42830780 | ||
| Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model | Q43659756 | ||
| Huntington's and myotonic dystrophy hESCs: down-regulated trinucleotide repeat instability and mismatch repair machinery expression upon differentiation | Q45300062 | ||
| Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness | Q45736205 | ||
| Requirement for COUP-TFI and II in the temporal specification of neural stem cells in CNS development | Q46152847 | ||
| Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease. | Q47811023 | ||
| Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell | Q48063176 | ||
| Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells | Q33392928 | ||
| Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells | Q33413336 | ||
| Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes | Q33730168 | ||
| The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles | Q33970945 | ||
| Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury | Q34004845 | ||
| Genetic variation of apolipoproteins in North Indians. | Q34166258 | ||
| Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides | Q34167801 | ||
| Induced pluripotent stem cells: past, present, and future | Q34281955 | ||
| Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells | Q34321823 | ||
| Steps toward safe cell therapy using induced pluripotent stem cells | Q34325607 | ||
| Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA⋅TTC triplet repeat instability | Q34330367 | ||
| From stealing fire to cellular reprogramming: a scientific history leading to the 2012 Nobel Prize | Q34372447 | ||
| Increased l1 retrotransposition in the neuronal genome in schizophrenia | Q34395700 | ||
| Generation of corneal epithelial cells from induced pluripotent stem cells derived from human dermal fibroblast and corneal limbal epithelium. | Q34429038 | ||
| Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity | Q34541218 | ||
| A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord | Q34572480 | ||
| Mutations for Gaucher disease confer high susceptibility to Parkinson disease | Q34607524 | ||
| Variation in the safety of induced pluripotent stem cell lines | Q34991636 | ||
| Toward the development of a global induced pluripotent stem cell library | Q35008270 | ||
| Modeling human neurological disorders with induced pluripotent stem cells | Q35056065 | ||
| Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients | Q35175041 | ||
| Apolipoprotein E and renal disease. | Q35642245 | ||
| Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus | Q35692589 | ||
| Efficient and accurate homologous recombination in hESCs and hiPSCs using helper-dependent adenoviral vectors | Q35749996 | ||
| Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells | Q35966957 | ||
| PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy | Q36476931 | ||
| Zinc-finger nuclease-mediated correction of α-thalassemia in iPS cells | Q36528994 | ||
| Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue | Q36539066 | ||
| Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury | Q36565225 | ||
| Enhanced aggregation of androgen receptor in induced pluripotent stem cell-derived neurons from spinal and bulbar muscular atrophy | Q36708477 | ||
| A human Dravet syndrome model from patient induced pluripotent stem cells | Q36849503 | ||
| Impact of recent genetic findings in Parkinson's disease | Q36874881 | ||
| Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism | Q37179285 | ||
| The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study | Q37251058 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | regenerative medicine | Q1061415 |
| nervous system | Q9404 | ||
| central nervous system disease | Q5062122 | ||
| biomedical investigative technique | Q66648976 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 22 | |
| P577 | publication date | 2014-03-31 | |
| P1433 | published in | Molecular Brain | Q6895938 |
| P1476 | title | iPS cell technologies: significance and applications to CNS regeneration and disease | |
| P478 | volume | 7 |
| Q88923991 | 3D bioprinter applied picosecond pulsed electric fields for targeted manipulation of proliferation and lineage specific gene expression in neural stem cells |
| Q42577149 | Activity and High-Order Effective Connectivity Alterations in Sanfilippo C Patient-Specific Neuronal Networks. |
| Q37563507 | An Integrated Miniature Bioprocessing for Personalized Human Induced Pluripotent Stem Cell Expansion and Differentiation into Neural Stem Cells |
| Q37648244 | Analysis of induced pluripotent stem cells carrying 22q11.2 deletion |
| Q26799331 | Applications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative Diseases |
| Q39136445 | Applications of induced pluripotent stem cell technologies in spinal cord injury |
| Q36138820 | Bioengineered Lacrimal Gland Organ Regeneration in Vivo |
| Q26753857 | Biomedical Application of Dental Tissue-Derived Induced Pluripotent Stem Cells |
| Q45740164 | Cell Therapy for Parkinson's Disease |
| Q28080770 | Cell reprogramming and neuronal differentiation applied to neurodegenerative diseases: Focus on Parkinson's disease |
| Q59335768 | Cell-Biological Requirements for the Generation of Dentate Gyrus Granule Neurons |
| Q41841616 | Cellular Zinc Homeostasis Contributes to Neuronal Differentiation in Human Induced Pluripotent Stem Cells |
| Q36860891 | Cloning and variation of ground state intestinal stem cells |
| Q35684598 | Connectivity and circuitry in a dish versus in a brain |
| Q28543575 | Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation |
| Q38820880 | Controlling the Regional Identity of hPSC-Derived Neurons to Uncover Neuronal Subtype Specificity of Neurological Disease Phenotypes |
| Q33917317 | Creation of a library of induced pluripotent stem cells from Parkinsonian patients. |
| Q92457992 | Crosstalk between stem cell and spinal cord injury: pathophysiology and treatment strategies |
| Q38836237 | DNA Transposition at Work |
| Q49843389 | Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson's disease-like motor dysfunction |
| Q47318536 | Engineering new neurons: in vivo reprogramming in mammalian brain and spinal cord |
| Q39427516 | Epigenetic regulation of neural stem cell differentiation towards spinal cord regeneration |
| Q36805034 | Establishment of In Vitro FUS-Associated Familial Amyotrophic Lateral Sclerosis Model Using Human Induced Pluripotent Stem Cells. |
| Q40278164 | Establishment of a Human Blood-Brain Barrier Co-culture Model Mimicking the Neurovascular Unit Using Induced Pluri- and Multipotent Stem Cells. |
| Q60301825 | Estimating the concentration of therapeutic range using disease-specific iPS cells: Low-dose rapamycin therapy for Pendred syndrome |
| Q64910709 | Examining the fundamental biology of a novel population of directly reprogrammed human neural precursor cells. |
| Q37707825 | Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives |
| Q38807798 | Forced cell cycle exit and modulation of GABAA, CREB, and GSK3β signaling promote functional maturation of induced pluripotent stem cell-derived neurons. |
| Q52916380 | Functional Comparison of Neuronal Cells Differentiated from Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells under Different Oxygen and Medium Conditions. |
| Q36760607 | Fyn Kinase regulates GluN2B subunit-dominant NMDA receptors in human induced pluripotent stem cell-derived neurons |
| Q92066386 | Generation and Characterization of Induced Pluripotent Stem Cells from Mononuclear Cells in Schizophrenic Patients |
| Q47142501 | Generation of Induced Pluripotent Stem Cells and Neural Stem/Progenitor Cells from Newborns with Spina Bifida Aperta |
| Q91843325 | Genetic conversion of proliferative astroglia into neurons after cerebral ischemia: a new therapeutic tool for the aged brain? |
| Q38945910 | Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications |
| Q90247278 | Homing of Super Paramagnetic Iron Oxide Nanoparticles (SPIONs) Labeled Adipose-Derived Stem Cells by Magnetic Attraction in a Rat Model of Parkinson's Disease |
| Q51283016 | Human Neural Tissue Construct Fabrication Based on Scaffold-Free Tissue Engineering. |
| Q90196682 | In Vitro Modeling of the Bipolar Disorder and Schizophrenia Using Patient-Derived Induced Pluripotent Stem Cells with Copy Number Variations of PCDH15 and RELN |
| Q92266693 | In vivo direct reprogramming of glial linage to mature neurons after cerebral ischemia |
| Q64259791 | Increased Cytotoxicity of Herpes Simplex Virus Thymidine Kinase Expression in Human Induced Pluripotent Stem Cells |
| Q26748907 | Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord Injury |
| Q41862093 | Induced pluripotent stem cells restore function in a human cell loss model of open-angle glaucoma |
| Q38342080 | Intranasal delivery of stem cells as therapy for central nervous system disease |
| Q38930831 | In Vivo Reprogramming for CNS Repair: Regenerating Neurons from Endogenous Glial Cells |
| Q90459814 | Layer-By-Layer: The Case for 3D Bioprinting Neurons to Create Patient-Specific Epilepsy Models |
| Q58107623 | Laying the groundwork for a first-in-human study of an iPSC-based intervention for spinal cord injury |
| Q42374879 | Low immunogenicity of mouse induced pluripotent stem cell-derived neural stem/progenitor cells |
| Q42348058 | MIF: functions in brain and glioblastoma |
| Q37304493 | Modeling neurological diseases with induced pluripotent cells reprogrammed from immortalized lymphoblastoid cell lines |
| Q91048657 | Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent |
| Q38816786 | Modeling the autistic cell: iPSCs recapitulate developmental principles of syndromic and nonsyndromic ASD. |
| Q38936382 | Myelin repair by transplantation of myelin-forming cells in globoid cell leukodystrophy |
| Q33757336 | Myogenic differentiation of VCP disease-induced pluripotent stem cells: A novel platform for drug discovery |
| Q91880863 | New frontiers in modeling tuberous sclerosis with human stem cell-derived neurons and brain organoids |
| Q91741049 | Omics Approach to Axonal Dysfunction of Motor Neurons in Amyotrophic Lateral Sclerosis (ALS) |
| Q37264786 | Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases |
| Q38904862 | Phenotypic screening with primary neurons to identify drug targets for regeneration and degeneration. |
| Q28077285 | Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD) |
| Q42677652 | Priming with FGF2 stimulates human dental pulp cells to promote axonal regeneration and locomotor function recovery after spinal cord injury |
| Q37642955 | Proteasome impairment in neural cells derived from HMSN-P patient iPSCs |
| Q92478922 | Recent Progress in the Regeneration of Spinal Cord Injuries by Induced Pluripotent Stem Cells |
| Q93066191 | Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies |
| Q38369065 | Regenerative medicine for Parkinson's disease |
| Q38539382 | Regenerative therapy for hippocampal degenerative diseases: lessons from preclinical studies |
| Q35789597 | Reprogramming patient-derived cells to study the epilepsies |
| Q36702988 | Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage |
| Q49890626 | Role of Exosomes Derived from miR-133b Modified MSCs in an Experimental Rat Model of Intracerebral Hemorrhage |
| Q55401574 | Rostrocaudal Areal Patterning of Human PSC-Derived Cortical Neurons by FGF8 Signaling. |
| Q36001692 | Rotenone Susceptibility Phenotype in Olfactory Derived Patient Cells as a Model of Idiopathic Parkinson's Disease |
| Q41863028 | SOX9 as a Predictor for Neurogenesis Potentiality of Amniotic Fluid Stem Cells |
| Q59349753 | Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury |
| Q33742361 | Sequential EMT-MET induces neuronal conversion through Sox2. |
| Q38669057 | Stem Cells in Neurotoxicology/Developmental Neurotoxicology: Current Scenario and Future Prospects |
| Q38341972 | Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact? |
| Q64977637 | Stem cells purified from human induced pluripotent stem cell-derived neural crest-like cells promote peripheral nerve regeneration. |
| Q91525177 | Synaptic deficits in iPSC-derived cortical interneurons in schizophrenia are mediated by NLGN2 and rescued by N-acetylcysteine |
| Q57818216 | T-type Calcium Channels Determine the Vulnerability of Dopaminergic Neurons to Mitochondrial Stress in Familial Parkinson Disease |
| Q37531034 | The silver lining of induced pluripotent stem cell variation |
| Q50130531 | Translational Advances in the Management of Acute Spinal Cord Injury: What is New? What is Hot? |
| Q38738492 | Traumatic Spinal Cord Injury-Repair and Regeneration |
| Q38834545 | Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects |
| Q26784399 | Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients |
| Q89763736 | Unveiling synapse pathology in spinal bulbar muscular atrophy by genome-wide transcriptome analysis of purified motor neurons derived from disease specific iPSCs |
| Q48292641 | Whole-Genome DNA Methylation Analyses Revealed Epigenetic Instability in Tumorigenic Human iPS Cell-Derived Neural Stem/Progenitor Cells |
| Q28087189 | iPS cell transplantation for traumatic spinal cord injury |
| Q47906823 | iPSC-derived neural precursor cells: potential for cell transplantation therapy in spinal cord injury |
| Q89920489 | miRNA-Based Rapid Differentiation of Purified Neurons from hPSCs Advancestowards Quick Screening for Neuronal Disease Phenotypes In Vitro |
Search more.